Company Updates
Alcidion Set to Trial Miya Patient Flow
Alcidion Set to Trial Miya Patient Flow
iFAST Corporation Corporate Profile and Annual Report 2015
29th March 2016, iFAST Corporation Chairman & CEO’s Message 2015 was our first full financial year since our IPO in December 2014. In many ways, 2015 was a continuation of our mission with our investors and wealth advisers, and we have achieved a number of milestones despite a challenging market environment. Our mission statement, “To help […]
Altech Share Placement and Share Purchase Plan
24th March 2016, ASX Announcement Highlights: $1.2 million raised via a share placement to professional and sophisticated investors Existing Shareholders invited to participate via a Share Purchase Plan Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to advise it has raised $1.2 million via a placement of shares to a variety of professional and […]
WYZA Announces New Partnerships With Australian Name Brands
21st March 2016, LinkedIn In recent weeks, we’ve announced a number of new partnerships with some of Australia’s leading name brands, including Blackmores, First National Real Estate and OnMarket BookBuilds. WYZA was created with a mission to serve as a ‘one-stop shop’ for Australia’s powerful 50+ demographic, delivering curated content, interactive services and social networks […]
OncoSil Medical Investor Presentation March 2016
23rd March 2016, ASX Announcement OncoSil Medical Limited (ASX: OSL) (OncoSil Medical, the Company) is pleased to release its latest Investor Presentation, delivered at Bell Potter Securities Limited’s Emerging Leaders Day in Sydney. The Presentation provides an overview and update on the Company’s activities and operations. OncoSil Medical is focused on regulatory approval and commercialisation […]
YPB Group Receive New Mexican Order for Vital Record Documents
23rd March 2016, ASX Announcement YPB Group Limited (ASX: YPB) has received an order for 700,000 vital record documents for the State of Guanajuato in Mexico, the second order resulting from the recently announced six year joint venture (JV) with Affyrmx LLC. Terms of the order are commercial in confidence, however as previously announced, typically […]
Folkestone Distribution Reinvestment Plan
23rd March 2016 In accordance with the 2016 full year distribution guidance of 13.4 cents per unit (cpu), Folkestone Investment Management Limited as the responsible entity of the Folkestone Education Trust (FET) gives notice that the distribution for the quarter ending 31 March 2016 is 3.35 cpu. The following dates apply to the distribution for […]
Proteomics Commences Therapeutic Drug Discovery Program
23rd Marc h 2016, ASX Announcement Highlights: PILL to utilise its proprietary disruptive technology platform to assess potential new painkilling and antibiotic drug compounds. Therapeutic Drug Discovery is one of PILL’s core business areas and is a major growth market – peptide therapeutics market estimated value is $17b. Program is low cost and has potential […]
iFAST Corporation Performance Share Plan
22nd March 206, iFAST Announcement The Board of Directors of iFAST Corporation Ltd (“the Company”) refers to the announcement released on 1 March 2016 relating to the grant of awards pursuant to the iFAST Corporation Performance Share Plan (“iFAST PSP”). The Company wishes to clarify as follow: Number of share awards granted was 1,296,200 and […]
Backed By Leading Investment Groups and Family Offices
